Use of high‐normal levels of haemoglobin A1C and fasting plasma glucose for diabetes screening and for prediction: a meta‐analysis
Published Nov 1, 2013 · S. Kodama, C. Horikawa, K. Fujihara
Diabetes/Metabolism Research and Reviews
24
Citations
2
Influential Citations
Abstract
Using high‐normal levels of haemoglobin A1C (Abnormal‐A1C) or fasting plasma glucose (FPG) (Abnormal‐FPG) for diabetes screening are expected to improve the ability to detect persons with or at high risk of diabetes. We assessed the diagnostic and predictive capacity for diabetes of Abnormal‐A1C and Abnormal‐FPG. We compared these to the combined use of the two measures to the single use of either measurement.
Study Snapshot
Key takeawayUsing high-normal levels of haemoglobin A1C and fasting plasma glucose for diabetes screening improves detection and predicts diabetes risk more effectively than using either measure alone.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.